Guggenheim Keeps Their Buy Rating on Tarsus Pharmaceuticals (TARS)
at www.tipranks.com (Thu, 5-Nov 7:16 AM)
Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE), Waters (WAT) and Tarsus Pharmaceuticals (TARS)
at www.tipranks.com (Wed, 4-Nov 4:00 PM)
Tarsus Pharmaceuticals, Inc. GAAP EPS of -$14.40 misses by $10.38, revenue of $194.5M beats by $3.72M
at seekingalpha.com (Tue, 3-Nov 4:52 PM)
